BRAF and melanoma: Recent work in melanoma showed that overexpression of CSF1R can occur in melanomas with activating BRAF or MAPK mutations and is associated with resistance to BRAF inhibitors.20 Because the interaction of these 2 pathways in DIPG is not known, we did not consider these concordant DNA and RNA findings.